CrossRef Cited By Search Results
This article [doi:10.1038/sj.onc.1210134] has been cited in the following papers, taken from those publishers and societies that are participating in CrossRef's Cited-by Linking service. The number of citations from this service is usually lower than citation numbers from databases that include more journals.
BACK TO ARTICLE-
EISSN: 09509232 ISSN: 09509232
Oncogene
TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP
28 (23), 2009, p.2257
-
EISSN: 17487838 ISSN: 10010602
Cell Research
TRAIL receptor mediates inflammatory cytokine release in an NF-κB-dependent manner
19 (6), 2009, p.758
-
EISSN: 17496632 ISSN: 00778923
Annals of the New York Academy of Sciences
Is There a Role for Nuclear Factor κB in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance?
1171 (1), 2009, p.38
-
EISSN: 16000625 ISSN: 09066705
Experimental Dermatology
Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication-competent CD95L adenovirus
-
EISSN: 12979716 ISSN: 09284249
Veterinary Research
Acute induction of cell death-related IFN stimulated genes (ISG) differentiates highly from moderately virulent CSFV strains
41 (1), 2010, p.07
-
EISSN: 09509232 ISSN: 09509232
Oncogene
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis
27 (22), 2008, p.3211
-
EISSN: 14728222 ISSN: 14728222
Expert Opinion on Therapeutic Targets
TRAIL in cancer therapy: present and future challenges
11 (10), 2007, p.1299